Skip to main content
Log in

An in vitro procedure for the estimation of thyroid hormone releasing factors in sera of thyrotoxic patients

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

LATS containing sera and a number of Graves’ disease sera stimulated T4 release from mouse thyroids in vitro as, determined by RIA, thus confirming the presence of a thyroid hormone releasing factor in sera of thyrotoxic patients. The pattern of stimulation was similar to that previously shown for TSH in terms of T4 release time sequence, cAMP increase and catecholamine inhibition via or-adrenergic receptors. In the same in vitro system, neutralization with a human thyroid homogenate showed presence of LATS-Protector (LPA) in LATS negative thyrotoxic sera. The present study describes a simpler procedure for estimating LATS or similar activity, as compared to the McKenzie assay, and suggests identical receptor sites for TSH and other thyroid stimulators.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. McKenzie J.M. Long acting thyroid stimulator of Graves’ disease. In: Greer M.A. and Solomon D.H., (Eds), Handbook of Physiology, Endocrinology III. The Thyroid. Am. Physiol. Soc. Wash., D.C., p. 285, 1974.

    Google Scholar 

  2. Gafni M., Sirkis N., Gross J. Inhibition of the response of mouse thyroid to thyrotropin induced by chronic triiodothyronine treatment. Endocrinology 97: 1256, 1975.

    Article  CAS  PubMed  Google Scholar 

  3. Brown J., Munro D.S. A new in vitro assay for thyroid stimulating hormone. J. Endocrinol. 38: 439, 1967.

    Article  CAS  PubMed  Google Scholar 

  4. Williams JA, Wolff J. Thyroid secretion in vitro: multiple actions of agents affecting secretion. Endocrinology 88: 206, 1971.

    Article  CAS  PubMed  Google Scholar 

  5. Maayan M.L., Debons A.F., Krimsky I., Volpert E.M., From A., Dawry F., Siclari E. Inhibition of thyrotropin and dibutyryl cyclic AMP induced secretion of thyroxine and triiodothyronine by catecholamines. Endocrinology 101: 284, 1977.

    Article  CAS  PubMed  Google Scholar 

  6. Adams D.D., Kennedy T.H. Occurrence in thyrotoxicosis of a gamma globulin which protects LATS from neutralization by an extract of thyroid gland. J. Clin. Endocrinol. Metab. 27: 173, 1970.

    Article  Google Scholar 

  7. Solomon D.H., Chopra I.J., Chopra V., Smith F.J. Identification of sub-groups of euthyroid Graves’ ophthalmopathy. N. Engl. J. Med. 296: 181, 1977.

    Article  CAS  PubMed  Google Scholar 

  8. Knox A.J.S., VonWestarp C., Row V.V., Volpé R. Thyroid antigen stimulates lymphocytes from patients with Graves’ disease to produce thyroid stimulating immunoglobulins. J. Clin. Endocrinol. Metab. 43: 330, 1976.

    Article  CAS  PubMed  Google Scholar 

  9. Volpert E.M. Iodoamino acids in normal and iodine-deficient rat thyroids; comparison between 125l and 127l distribution. Endocrinology 93: 1241, 1973.

    Article  CAS  PubMed  Google Scholar 

  10. Wood L.C., Burger A., Peterson M., Ingbar S.H. Induction of a LATS-like response by thyroglobulin in the McKenzie assay system. Endocrinology 92: 1538, 1973.

    Article  CAS  PubMed  Google Scholar 

  11. Wolff J., Cook G.H. Charge effects in the activation of adenylate cyclase. J. Biol. Chem. 250: 6897, 1975.

    CAS  PubMed  Google Scholar 

  12. Hall R., Smith B.R., Mukhtar E.D. Thyroid stimulators in health and disease. Clin. Endocrinol. (Oxf.) 4: 213, 1975.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Maayan, M.L., Volpert, E.M. & Dawry, F.P. An in vitro procedure for the estimation of thyroid hormone releasing factors in sera of thyrotoxic patients. J Endocrinol Invest 1, 299–304 (1978). https://doi.org/10.1007/BF03350973

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03350973

Key-words

Navigation